Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.694866
Title: Quantitative imaging of the liver with 18F-FDG PET/CT in patients with hepatic steatosis
Author: Keramida, Georgia
ISNI:       0000 0004 5993 1213
Awarding Body: University of Brighton
Current Institution: University of Brighton
Date of Award: 2016
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Background and Aims: Hepatic steatosis (≥10% fat within the liver) affects ~75% of obese and ~15% of non-obese adults. It leads to steatohepatitis (SH) in ~10% of patients. SH may then lead to cirrhosis. The primary aim of the thesis was to image the liver with FDG PET/CT to determine if glucose utilisation rate (MRglu) is increased in steatosis. Texture analysis of FDG PET/CT was also explored as a means of detecting steatosis and SH. Previous PET studies of steatosis quantified hepatic FDG uptake as the standardised uptake value (SUV). Methods: All patients were referred for routine PET/CT. ROI were placed over the liver on whole body scans for measurement of CT density, which is inversely proportional to hepatic fat content, and SUV. SUV may be expressed as the ‘hottest’ pixel (SUVmax) or as the average of all pixels in the ROI (SUVave). Dynamic imaging from 0-30 min post-injection was also done in 60 patients and hepatic FDG clearance and MRglu were measured using Patlak-Rutland analysis. Texture analysis of PET and CT scans was explored as possible means of identifying SH at an early stage. Results: SUV was overestimated in obese individuals when calculated using weight but not when using estimated lean body mass. SUVmax, but not SUVave, was increased in steatosis because SUVave is reduced in fatty liver as a result of ‘signal dilution’ by the fat. SUVmax/SUVave is therefore a marker of steatosis. Hepatic FDG clearance and MRglu were increased in steatosis, irrespective of BMI, but not in obese patients who did not have steatosis. Results of texture analysis were promising but inconclusive. Conclusions and future work: SUV has major shortcomings as a surrogate for FDG clearance but in general indicates increased MRglu in steatosis. Dynamic studies confirm that MRglu is increased in steatosis. SUVmax/SUVave is a marker of steatosis. Future work should aim to a) use dynamic FDG imaging to diagnose hepatic inflammation, and b) explore texture analysis to detect transition from steatosis to SH.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.694866  DOI: Not available
Keywords: A000 Medicine
Share: